One out of every three people living with HIV in Latin America does not know this because there is no culture of stigmatization and prevention.Carlos Magis for the prevention and control of HIV / AIDS (Censida) from the National Center of Mexico.
"There is still a delay in the diagnosis of a person diagnosed and treated today despite having a high life expectancy", Said Magis, director of comprehensive care for Censida.
The doctor explained with the current therapies, Life expectancy in these infected people is up to 40 years.
Brenda Crabtree Ramírez, head of the International AIDS Association (AIDS) Violence, stigmatization and prevention and inequality in access to information have become the most important obstacles to be overcome.
"It is a fact that the AIDS epidemic will not be attacked effectively unless we fight against it.", he claimed.
Among the experts said: People with fewer determinations are mostly heterosexual men and the elderly.
"Especially in this last group, they are slow to perceive that they are at risk because there is a big stigma about this disease.", Juan Sierra, chairman of the infection department in Salvador Zubirán, Institute of Medical Sciences and Nutrition in Mexico.
In Mexico, according to Censida, a little more At present, 141,000 people are undergoing retroviral treatment, and since 1996, the mortality rate is decreasing, but 5,000 people die annually. For this disease.
"Patients are improved with the treatments we offer at the Ministry of Health and 51% of those diagnosed and treated reduce viral load every six months "dedi Magis.
Added this One of the shortcomings of the region is that pharmacy tests are not yet available for the population.It is open to anyone who wants to do a quick test in countries like the United States.
Decreasing treatment costs would be very useful in countries like Mexico, he added. Spending on HIV treatment is one-third of Seguro Popular's disaster expense fund.
"Public policies should aim to improve access to treatment, and one option is to reduce costs." to make consolidated purchases of drugs and allow more drugs to reach Mexico. "
With the fact that the cost of treatment in regions such as Africa is based on generic retrovirals, the cost of treatment is $ 100 per year; while In Mexico, the cost to rely on patented drugs is $ 2,000.
Sierra said he had HIV In Mexico, in addition to stamping and discrimination, you must face an unfriendly health care system. follow the treatment.
Değil Unfortunately, we have a fragmented health system, and this is not very useful for people with diseases that need to be treated for life. Sometimes institutions are an obstacle to the continuity of HIV treatment"said.